Cargando…

CMR Tissue Characterization in Patients with HFmrEF

The characteristics and optimal management of heart failure with a moderately reduced ejection fraction (HFmrEF, LV-EF 40–50%) are still unclear. Advanced cardiac MRI offers information about function, fibrosis and inflammation of the myocardium, and might help to characterize HFmrEF in terms of adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Doeblin, Patrick, Hashemi, Djawid, Tanacli, Radu, Lapinskas, Tomas, Gebker, Rolf, Stehning, Christian, Motzkus, Laura Astrid, Blum, Moritz, Tahirovic, Elvis, Dordevic, Aleksandar, Kraft, Robin, Zamani, Seyedeh Mahsa, Pieske, Burkert, Edelmann, Frank, Düngen, Hans-Dirk, Kelle, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912482/
https://www.ncbi.nlm.nih.gov/pubmed/31694263
http://dx.doi.org/10.3390/jcm8111877
_version_ 1783479466360569856
author Doeblin, Patrick
Hashemi, Djawid
Tanacli, Radu
Lapinskas, Tomas
Gebker, Rolf
Stehning, Christian
Motzkus, Laura Astrid
Blum, Moritz
Tahirovic, Elvis
Dordevic, Aleksandar
Kraft, Robin
Zamani, Seyedeh Mahsa
Pieske, Burkert
Edelmann, Frank
Düngen, Hans-Dirk
Kelle, Sebastian
author_facet Doeblin, Patrick
Hashemi, Djawid
Tanacli, Radu
Lapinskas, Tomas
Gebker, Rolf
Stehning, Christian
Motzkus, Laura Astrid
Blum, Moritz
Tahirovic, Elvis
Dordevic, Aleksandar
Kraft, Robin
Zamani, Seyedeh Mahsa
Pieske, Burkert
Edelmann, Frank
Düngen, Hans-Dirk
Kelle, Sebastian
author_sort Doeblin, Patrick
collection PubMed
description The characteristics and optimal management of heart failure with a moderately reduced ejection fraction (HFmrEF, LV-EF 40–50%) are still unclear. Advanced cardiac MRI offers information about function, fibrosis and inflammation of the myocardium, and might help to characterize HFmrEF in terms of adverse cardiac remodeling. We, therefore, examined 17 patients with HFpEF, 18 with HFmrEF, 17 with HFrEF and 17 healthy, age-matched controls with cardiac MRI (Phillips 1.5 T). T1 and T2 relaxation time mapping was performed and the extracellular volume (ECV) was calculated. Global circumferential (GCS) and longitudinal strain (GLS) were derived from cine images. GLS (−15.7 ± 2.1) and GCS (−19.9 ± 4.1) were moderately reduced in HFmrEF, resembling systolic dysfunction. Native T1 relaxation times were elevated in HFmrEF (1027 ± 40 ms) and HFrEF (1033 ± 54 ms) compared to healthy controls (972 ± 31 ms) and HFpEF (985 ± 32 ms). T2 relaxation times were elevated in HFmrEF (55.4 ± 3.4 ms) and HFrEF (56.0 ± 6.0 ms) compared to healthy controls (50.6 ± 2.1 ms). Differences in ECV did not reach statistical significance. HFmrEF differs from healthy controls and shares similarities with HFrEF in cardiac MRI parameters of fibrosis and inflammation.
format Online
Article
Text
id pubmed-6912482
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69124822020-01-02 CMR Tissue Characterization in Patients with HFmrEF Doeblin, Patrick Hashemi, Djawid Tanacli, Radu Lapinskas, Tomas Gebker, Rolf Stehning, Christian Motzkus, Laura Astrid Blum, Moritz Tahirovic, Elvis Dordevic, Aleksandar Kraft, Robin Zamani, Seyedeh Mahsa Pieske, Burkert Edelmann, Frank Düngen, Hans-Dirk Kelle, Sebastian J Clin Med Article The characteristics and optimal management of heart failure with a moderately reduced ejection fraction (HFmrEF, LV-EF 40–50%) are still unclear. Advanced cardiac MRI offers information about function, fibrosis and inflammation of the myocardium, and might help to characterize HFmrEF in terms of adverse cardiac remodeling. We, therefore, examined 17 patients with HFpEF, 18 with HFmrEF, 17 with HFrEF and 17 healthy, age-matched controls with cardiac MRI (Phillips 1.5 T). T1 and T2 relaxation time mapping was performed and the extracellular volume (ECV) was calculated. Global circumferential (GCS) and longitudinal strain (GLS) were derived from cine images. GLS (−15.7 ± 2.1) and GCS (−19.9 ± 4.1) were moderately reduced in HFmrEF, resembling systolic dysfunction. Native T1 relaxation times were elevated in HFmrEF (1027 ± 40 ms) and HFrEF (1033 ± 54 ms) compared to healthy controls (972 ± 31 ms) and HFpEF (985 ± 32 ms). T2 relaxation times were elevated in HFmrEF (55.4 ± 3.4 ms) and HFrEF (56.0 ± 6.0 ms) compared to healthy controls (50.6 ± 2.1 ms). Differences in ECV did not reach statistical significance. HFmrEF differs from healthy controls and shares similarities with HFrEF in cardiac MRI parameters of fibrosis and inflammation. MDPI 2019-11-05 /pmc/articles/PMC6912482/ /pubmed/31694263 http://dx.doi.org/10.3390/jcm8111877 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Doeblin, Patrick
Hashemi, Djawid
Tanacli, Radu
Lapinskas, Tomas
Gebker, Rolf
Stehning, Christian
Motzkus, Laura Astrid
Blum, Moritz
Tahirovic, Elvis
Dordevic, Aleksandar
Kraft, Robin
Zamani, Seyedeh Mahsa
Pieske, Burkert
Edelmann, Frank
Düngen, Hans-Dirk
Kelle, Sebastian
CMR Tissue Characterization in Patients with HFmrEF
title CMR Tissue Characterization in Patients with HFmrEF
title_full CMR Tissue Characterization in Patients with HFmrEF
title_fullStr CMR Tissue Characterization in Patients with HFmrEF
title_full_unstemmed CMR Tissue Characterization in Patients with HFmrEF
title_short CMR Tissue Characterization in Patients with HFmrEF
title_sort cmr tissue characterization in patients with hfmref
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912482/
https://www.ncbi.nlm.nih.gov/pubmed/31694263
http://dx.doi.org/10.3390/jcm8111877
work_keys_str_mv AT doeblinpatrick cmrtissuecharacterizationinpatientswithhfmref
AT hashemidjawid cmrtissuecharacterizationinpatientswithhfmref
AT tanacliradu cmrtissuecharacterizationinpatientswithhfmref
AT lapinskastomas cmrtissuecharacterizationinpatientswithhfmref
AT gebkerrolf cmrtissuecharacterizationinpatientswithhfmref
AT stehningchristian cmrtissuecharacterizationinpatientswithhfmref
AT motzkuslauraastrid cmrtissuecharacterizationinpatientswithhfmref
AT blummoritz cmrtissuecharacterizationinpatientswithhfmref
AT tahirovicelvis cmrtissuecharacterizationinpatientswithhfmref
AT dordevicaleksandar cmrtissuecharacterizationinpatientswithhfmref
AT kraftrobin cmrtissuecharacterizationinpatientswithhfmref
AT zamaniseyedehmahsa cmrtissuecharacterizationinpatientswithhfmref
AT pieskeburkert cmrtissuecharacterizationinpatientswithhfmref
AT edelmannfrank cmrtissuecharacterizationinpatientswithhfmref
AT dungenhansdirk cmrtissuecharacterizationinpatientswithhfmref
AT kellesebastian cmrtissuecharacterizationinpatientswithhfmref